Management of chronic low back pain and the impact on patients' personal and professional lives: Results from an international patient survey
- PMID: 35156770
- PMCID: PMC9306505
- DOI: 10.1111/papr.13103
Management of chronic low back pain and the impact on patients' personal and professional lives: Results from an international patient survey
Abstract
Objective: The objective of this study was to investigate the impact of chronic low back pain (CLBP) on patients' personal and professional lives, and management strategies applied to treat CLBP.
Methods: A 60-question survey was developed, and respondents from 16 countries with a self-reported physician's diagnosis of CLBP were recruited via an online market research survey panel. Respondents were stratified as having mild, moderate, or severe pain. Target sample sizes per country and for pain severity were set. Data were weighted according to the known population and prevalence of CLBP in each country and the number of respondents from that country.
Results: Results from 9642 CLBP patients indicated that almost a quarter of patients with severe CLBP report a psychological comorbidity. Prescription pain medications were more commonly used by patients with severe CLBP (56%) than those with mild (20%) or moderate (34%) CLBP. Among those with severe CLBP who had been prescribed pain medication, 58% were prescribed opioids, with 1 in 4 patients using opioids for more than 5 years. Patients were primarily managed by general practitioners/primary care physicians, physiotherapists, neurologists, or orthopedic surgeons. CLBP negatively impacted patients' daily activities, social lives, and work productivity.
Conclusion: Chronic low back pain has pronounced effects on patients' personal relationships, ability to work, and daily living. Almost 1 in four patients with severe CLBP reported a psychological comorbidity. Adherence to guidelines appears inconsistent, which is noteworthy as a substantial subgroup of patients with severe CLBP had been prescribed opioid medication for more than 5 years. Improved education is required to support healthcare professionals (HCPs) in identifying and understanding the complex biopsychosocial needs of CLBP patients to optimize pain management and to encourage referral of CLBP patients to physiotherapists and psychologists.
Keywords: biopsychosocial model; chronic low back pain; international patient survey; pain management; psychological comorbidity.
© 2022 Pfizer Inc. Pain Practice published by Wiley Periodicals LLC on behalf of World Institute of Pain.
Conflict of interest statement
Bart Morlion and David Roomes have received grants for clinical research, consultancy activities, and speaker's activities from a number of pharmaceutical companies, including Pfizer Ltd and Eli Lilly and Company. Brona Fullen has received non‐restrictive educational grants and/or consultancy activities from pharmaceutical companies including Pfizer Ltd and Eli Lilly and Company. Joop van Griensven, Steven Linton, and Serge Perrot have received non‐restrictive grants for consultancy activities from Pfizer Ltd and Eli Lilly and Company. Craig Beck and Lucy Abraham are employees of Pfizer Ltd with stock and/or stock options. Stefan Wilhelm is an employee and shareholder of Eli Lilly and Company. Cristina Constantinescu is an employee of Ipsos SA, who were paid consultants to Pfizer Ltd and Eli Lilly and Company for this study and the development of this manuscript.
Figures




Similar articles
-
Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study.J Pain. 2018 Oct;19(10):1104-1112. doi: 10.1016/j.jpain.2018.04.004. Epub 2018 Apr 17. J Pain. 2018. PMID: 29678564 Free PMC article.
-
'Specialist before physiotherapist': physicians' and physiotherapists' beliefs and management of chronic low back pain in Ghana - A qualitative study.Disabil Rehabil. 2025 Feb;47(3):644-654. doi: 10.1080/09638288.2024.2356005. Epub 2024 May 20. Disabil Rehabil. 2025. PMID: 38767467
-
Chronic low back pain comorbidity count and its impact on exacerbating opioid and non-opioid prescribing behavior.Pain Pract. 2023 Mar;23(3):252-263. doi: 10.1111/papr.13185. Epub 2022 Dec 10. Pain Pract. 2023. PMID: 36447402
-
Substantive review of the literature of medication treatment of chronic low back pain among adults.J Am Assoc Nurse Pract. 2015 May;27(5):270-9. doi: 10.1002/2327-6924.12155. Epub 2014 Jul 25. J Am Assoc Nurse Pract. 2015. PMID: 25066498 Review.
-
Chronic low back pain beliefs and management practices in Africa: Time for a rethink?Musculoskeletal Care. 2019 Dec;17(4):376-381. doi: 10.1002/msc.1424. Epub 2019 Aug 16. Musculoskeletal Care. 2019. PMID: 31419001 Review.
Cited by
-
What do people living with chronic pain want from a pain forecast? A research prioritization study.PLoS One. 2023 Oct 12;18(10):e0292968. doi: 10.1371/journal.pone.0292968. eCollection 2023. PLoS One. 2023. PMID: 37824568 Free PMC article.
-
Development of a Person-Centred Coordinated Care Pathway in Swedish Healthcare for Low Back Pain.Int J Integr Care. 2025 May 9;25(2):8. doi: 10.5334/ijic.8940. eCollection 2025 Apr-Jun. Int J Integr Care. 2025. PMID: 40352957 Free PMC article.
-
Randomized-controlled trial assessing a digital care program versus conventional physiotherapy for chronic low back pain.NPJ Digit Med. 2023 Jul 7;6(1):121. doi: 10.1038/s41746-023-00870-3. NPJ Digit Med. 2023. PMID: 37420107 Free PMC article.
-
Use of General Practitioner Services Among Workers with Work-Related Low Back Pain: A Systematic Review.J Occup Rehabil. 2025 Mar;35(1):4-16. doi: 10.1007/s10926-024-10187-x. Epub 2024 Apr 23. J Occup Rehabil. 2025. PMID: 38652423 Free PMC article.
-
Digital Therapeutics (DTx) Expand Multimodal Treatment Options for Chronic Low Back Pain: The Nexus of Precision Medicine, Patient Education, and Public Health.Healthcare (Basel). 2023 May 18;11(10):1469. doi: 10.3390/healthcare11101469. Healthcare (Basel). 2023. PMID: 37239755 Free PMC article.
References
-
- Lodato EM, Kaplan W. Priority medicines for Europe and the world "a public health approach to innovation" update on the 2004 background paper. In: Kaplan W, Wirtz VJ, Mantel‐Teeuwisse A, Stolk P, Duthey B, Laing R, editors. Priority medicines for Europe and the world: 2013 updated background paper. Geneva: World Health Organization; 2013. p. 1–122.
-
- Global Burden of Disease Study 2013 Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. - PMC - PubMed
-
- Park TSW, Kuo A, Smith MT. Chronic low back pain: a mini‐review on pharmacological management and pathophysiological insights from clinical and pre‐clinical data. Inflammopharmacology. 2018;26:881–98. - PubMed
-
- Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical